Zoetis

Techcyte is a cloud-based, SaaS provider and world leader in AI-based cellular digital diagnostics. that uses deep learning image analysis to help labs and clinics become more efficient and accurate. The platform is HIPAA compliant, CE marked and supports tests across hematology, cytology, bacteriology and parasitology.  Techcyte's has solutions for human, veterinary and environmental clinics and labs.  Techcyte’s Clinical Pathology AI Platform uses deep machine learning to perform automated analysis of whole slide microscopy images, revolutionizing digital diagnostics for human, animal, and environmental clinics and labs.

Zoetis is committed to research, combining to help protect the health of pets and farm animals and the productivity.

<div>  <p>    Zoetis Inc. (NYSE: ZTS) is the world's leading animal health company, focused on developing and manufacturing medicines, vaccines, diagnostic products and other technologies for companion and livestock animals.  </p>  <p>    Zoetis offers a diverse portfolio of products across eight core animal species - cattle, swine, poultry, fish, sheep, dogs, cats and horses. Its product lines include vaccines, parasiticides, anti-infectives, medicated feed additives, and other pharmaceuticals. The company also provides diagnostic instruments and genetic tests for veterinary use. Key products include Apoquel and Cytopoint for dermatology, Simparica Trio for parasites, and Librela and Solensia for osteoarthritis pain in pets.  </p>  <p>    In 2023, Zoetis reported revenue of USD 8.5 billion, a 6% increase over the previous year. The company has a global presence, with products sold in over 100 countries. Zoetis continues to invest heavily in research and development, spending USD 508 million on R&amp;D in 2021. Recent innovations include the launch of AI-powered diagnostic tools and new vaccines for livestock. The company is also expanding its capabilities in areas like telemedicine and precision animal health to drive future growth in the evolving animal healthcare market.  </p></div>

The Arthritis Foundation Welcomes Zoetis as Two-Year Nati...

New insurance models are disrupting a centuries-old industry with a focus on personalization and convenience

InsurTech: Personal Lines

Startups in the automobile insurance space, predominantly providing usage-based insurance using telematics devices and/or smartphone sensors.

Startups that offer homeowners and renters insurance using artificial intelligence (AI) and smart home devices to issue policies and validate claims.

Startups that provide life insurance through digital channels personalized to an individual’s circumstances and replacing traditional practices, such as medical tests, with data-driven underwriting.

Companies that offer personal line covers for travel and pets through digital channels and use technologies such as flight tracking and online claims processing.

Providers of comparison websites and tools for carriers, agents, and consumers to compare and purchase policies.

Companies that provide personalized health insurance to consumers via digital channels and use technology such as wearable medical devices to monitor health and improve user experience and underwriting.

Companies that offer digital-only insurance for personal belongings (bicycles, mobile phones, laptops, and cameras), providing protection against theft, loss, or damage, with financial reimbursement or replacement.

Promoting the health, well-being, and ethical treatment of animals

Animal Therapeutics

Companies that offer specialized therapeutics for the diagnosis, treatment, and management of cancer in animals. This includes areas such as cancer diagnosis, surgery, chemotherapy, and immunotherapy.

Companies that develop vaccines and drugs for pets and livestock based on advanced research and biotechnologies such as DNA technology, with a specific focus on the treatment and prevention of diseases and medical conditions in animals.

Companies that use regenerative techniques and technologies to promote tissue repair, regeneration, and healing in animals. This involves stem cell therapy, platelet-rich plasma (PRP) therapy, tissue engineering, gene therapy, and wound healing treatments.

Companies that provide veterinary diagnostic services, which include a wide range of tests, procedures, and laboratory services to diagnose, monitor, and manage the health and well-being of animals. This includes laboratory testing, diagnostic imaging, endoscopy, and genetic testing.

Companies that provide specialized treatments aimed at extending the lifespan and improving the overall health and quality of life of animals, including companion animals and livestock. These approaches are designed to address the challenges of aging, prevent age-related diseases, and enhance the well-being of aging animals.

Driving livestock productivity using next-generation biotechnology

Livestock Biotech

Companies that offer solutions that edit (gene editing) or modify (gene modification) an animal's genome in a precise and targeted manner using methods such as TALEN's, CRISPR/Cas9, recombinant retroviruses, and sperm-mediated DNA transfer. The techniques change the existing genome to improve/express desired traits in livestock. The segment also covers companies that use an AI-based platform or otherwise to offer diagnostic testing services of the animal's genome that help livestock farmers identify genetic changes or diseases present in herds.

Companies that offer next-generation vaccines based on developments in DNA technology (e.g., mRNA vaccines) and biotechnology. The segment also includes medicines developed for the prevention and treatment of livestock diseases.

Companies that use a range of genetic techniques that can alter the DNA of animals more precisely than traditional breeding techniques. Techniques such as gender selection via sexed semen, genomic selection, or even gene editing methods like CRISPR are used to breed animals precisely with superior genetic traits.

Companies that produce natural ingredients or biological additives that can be added to animal feed for purposes such as improving nutrient uptake and the gut microbiome.

ANALYST_QUICK_TAKE

INCUMBENTS_PRESENT

PROMINENT_CATEGORY

<div>
 <p>Zoetis, an animal health company, is collaborating with Danone, a worldwide dairy and nutrition firm, to advance sustainable dairy farming using genetic technologies.</p>
 <p>Zoetis' genetic testing solutions, specifically the Dairy Wellness Profit Index from CLARIFIDE Plus, are being utilized to enhance animal health, lower environmental consequences, and boost farm resilience. This alliance is in line with Danone's commitment to ecological responsibility and sustainable dairy farming.</p>
 <p>The joint plan focuses on the integration of sustainable practices into dairy genetics and selection, aiming for healthier cows that can contribute to the sustainability of the dairy sector. Positive outcomes such as improved environment, greater cow lifespan, and meeting the increasing demand for sustainably sourced dairy products are anticipated from this partnership.</p>
 
</div> <p><b>Analyst QuickTake:<br>
 </b> The Dairy Wellness Profit Index (DWP$) from CLARIFIDE Plus is a genomic tool that estimates an animal's potential lifetime profit based on multiple traits. It is the first genomic test in the US to provide insights into eight cow wellness traits—including mastitis, lameness, and ketosis—along with three calf wellness traits and three fertility traits, all in one package.&nbsp;</p>

Zoetis

Featured Industries

EDGE Insights

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless